Total Payments
$4,332
2024 Payments
$1,589
Companies
32
Transactions
285
Medicare Patients
2,087
Medicare Billing
$141,360
Payment Breakdown by Category
Food & Beverage$4,332 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,332 | 285 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $736.13 | 50 | $0 (2024) |
| ABBVIE INC. | $702.00 | 55 | $0 (2024) |
| Lilly USA, LLC | $570.79 | 44 | $0 (2024) |
| PFIZER INC. | $353.00 | 25 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $324.26 | 18 | $0 (2024) |
| Amgen Inc. | $252.75 | 15 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $187.76 | 11 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $150.80 | 8 | $0 (2024) |
| Dexcom, Inc. | $117.84 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $112.21 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,589 | 97 | Novo Nordisk Inc ($242.42) |
| 2023 | $1,361 | 92 | ABBVIE INC. ($292.69) |
| 2022 | $1,224 | 85 | Novo Nordisk Inc ($225.43) |
| 2021 | $103.44 | 7 | DEXCOM, INC. ($35.99) |
| 2018 | $31.93 | 2 | Grifols USA, LLC ($31.93) |
| 2017 | $23.09 | 2 | Novo Nordisk Inc ($23.09) |
All Payment Transactions
285 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Obesity | ||||||
| 12/06/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Hematology | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: PAIN | ||||||
| 11/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: VACCINES | ||||||
| 10/21/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: PAIN | ||||||
| 10/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Biological | ||||||
| 10/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus, Tresiba | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.83 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.32 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $9.52 | General |
| Category: VACCINES | ||||||
| 09/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: PAIN | ||||||
| 09/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: DIABETES | ||||||
| 09/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: Obesity | ||||||
| 08/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 686 | 933 | $155,643 | $61,337 |
| 2022 | 11 | 449 | 540 | $87,536 | $32,190 |
| 2021 | 8 | 451 | 534 | $60,853 | $25,669 |
| 2020 | 10 | 501 | 605 | $63,312 | $22,164 |
Total Patients
2,087
Total Services
2,612
Medicare Billing
$141,360
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 169 | 245 | $51,930 | $19,867 | 38.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 129 | 169 | $24,792 | $9,486 | 38.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 74 | 74 | $16,414 | $8,958 | 54.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 38 | 88 | $8,976 | $4,118 | 45.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 46 | 46 | $14,490 | $4,099 | 28.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 13 | 13 | $8,606 | $3,663 | 42.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 42 | 42 | $7,770 | $3,018 | 38.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 18 | 18 | $5,904 | $2,792 | 47.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 20 | 59 | $8,437 | $2,013 | 23.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 43 | 43 | $1,505 | $1,244 | 82.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 15 | 31 | $3,472 | $1,046 | 30.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 35 | 47 | $2,068 | $447.44 | 21.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $455.00 | $376.09 | 82.7% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 11 | 11 | $484.00 | $136.70 | 28.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 20 | 34 | $340.00 | $74.80 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 100 | 144 | $30,096 | $12,448 | 41.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 83 | 83 | $26,145 | $7,233 | 27.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 78 | 94 | $13,536 | $5,002 | 37.0% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 14 | 16 | $5,680 | $2,334 | 41.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 25 | 25 | $2,925 | $1,710 | 58.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 12 | 12 | $2,652 | $1,482 | 55.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 27 | 27 | $945.00 | $742.79 | 78.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 17 | 17 | $3,502 | $742.42 | 21.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 61 | 87 | $957.00 | $256.45 | 26.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 19 | 22 | $968.00 | $210.67 | 21.8% |
About Sarah Lim
Sarah Lim is a Internal Medicine healthcare provider based in Lexington, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2012. The National Provider Identifier (NPI) number assigned to this provider is 1891051959.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sarah Lim has received a total of $4,332 in payments from pharmaceutical and medical device companies, with $1,589 received in 2024. These payments were reported across 285 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($4,332).
As a Medicare-enrolled provider, Lim has provided services to 2,087 Medicare beneficiaries, totaling 2,612 services with total Medicare billing of $141,360. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Lexington, SC
- Active Since 04/03/2012
- Last Updated 09/15/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1891051959
Products in Payments
- MOUNJARO (Drug) $304.59
- NURTEC ODT (Drug) $273.86
- QULIPTA (Drug) $268.78
- VRAYLAR (Drug) $248.78
- Ozempic (Drug) $208.95
- JARDIANCE (Drug) $188.18
- XIFAXAN (Drug) $187.76
- FARXIGA (Drug) $187.02
- UBRELVY (Drug) $184.44
- Rybelsus (Drug) $136.62
- Otezla (Drug) $132.84
- ELIQUIS (Drug) $108.55
- TRADJENTA (Drug) $90.20
- ZEPBOUND (Drug) $83.18
- AIRSUPRA (Drug) $81.95
- Dexcom G6 Transmitter (Medical Supply) $81.85
- LEQVIO (Drug) $78.69
- Aimovig (Biological) $74.06
- SHINGRIX (Biological) $73.42
- Wegovy (Drug) $72.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lexington
Dr. Firas Badin, M.d, M.D
Internal Medicine — Payments: $1.9M
Internal Medicine $1.9M
Dennis Doherty, Md, MD
Internal Medicine — Payments: $686,622
Internal Medicine $686,622
Dr. Robert Sawyer, M.d, M.D
Internal Medicine — Payments: $232,104
Internal Medicine $232,104
David Mannino, Md, MD
Internal Medicine — Payments: $140,029
Internal Medicine $140,029
Dr. Anastasia Jandes, Md, MD
Internal Medicine — Payments: $90,742
Internal Medicine $90,742
Gloria Vigliani, M.d, M.D
Internal Medicine — Payments: $89,452
Internal Medicine $89,452